Insulin human Completed Phase 2 Trials for Type 2 Diabetes Mellitus / Diabetes Mellitus (DM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00511719Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes
NCT01526980Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes
NCT00660374Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes
NCT01697618Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes
NCT00143338To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.
NCT00698802Safety and Efficacy of Biphasic Human Insulin Compared to EX1000 in Type 2 Diabetes
NCT00624767A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients
NCT01000922A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECTâ„¢, Regular Human Insulin, and Insulin Lispro